One possibility is that cancer-associated mutations of the N-terminal domain of BUB1 impair stabilizing interactions with BUB1 residues C-terminal to this domain that are not present in the crystallized protein (for instance, with those located in the adjacent BUB3 binding region). The gene discussed is BUB3; the disease is cancer.